
pmid: 12811112
The use of the words "drug" and "policy" together highlights some of the inconsistencies and ironies in healthcare delivery in Canada. Not that the legislators and the government mandarins don't try to create and implement policy, but events (and the pharmaceutical industry) are always one step ahead so the policy-makers find themselves in the role of "follower" rather than "leader." It is time to re-examine the current approach to decision-making about pharmaceuticals and to identify a process that allows all Canadians to receive the care that was promised with the passage of the Canada Health Act.
Canada, Evidence-Based Medicine, National Health Programs, Information Dissemination, Cost-Benefit Analysis, Health Policy, Drug Utilization, Leadership, Drug Information Services, Drug and Narcotic Control, Humans, Policy Making, Decision Making, Organizational
Canada, Evidence-Based Medicine, National Health Programs, Information Dissemination, Cost-Benefit Analysis, Health Policy, Drug Utilization, Leadership, Drug Information Services, Drug and Narcotic Control, Humans, Policy Making, Decision Making, Organizational
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
